Fu Rong - Net Worth and Insider Trading

Fu Rong Net Worth

The estimated net worth of Fu Rong is at least $1 Million dollars as of 2025-04-09. Fu Rong is the Executives of Chongqing Lummy Pharmaceutical and owns about 440,200 shares of Chongqing Lummy Pharmaceutical (SZSE:300006) stock worth over $1 Million. Details can be seen in Fu Rong's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Fu Rong has not made any transactions after 2014-09-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Fu Rong

To

Fu Rong Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Fu Rong owns 1 companies in total, including Chongqing Lummy Pharmaceutical (SZSE:300006) .

Click here to see the complete history of Fu Rong’s form 4 insider trades.

Insider Ownership Summary of Fu Rong

Ticker Comapny Transaction Date Type of Owner
SZSE:300006 Chongqing Lummy Pharmaceutical 2014-09-12 Executives

Fu Rong Latest Holdings Summary

Fu Rong currently owns a total of 1 stock. Fu Rong owns 440,200 shares of Chongqing Lummy Pharmaceutical (SZSE:300006) as of September 12, 2014, with a value of $1 Million.

Latest Holdings of Fu Rong

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SZSE:300006 Chongqing Lummy Pharmaceutical 2014-09-12 440,200 3.13 1,377,826

Holding Weightings of Fu Rong


Fu Rong Form 4 Trading Tracker

According to the SEC Form 4 filings, Fu Rong has made a total of 0 transactions in Chongqing Lummy Pharmaceutical (SZSE:300006) over the past 5 years. The most-recent trade in Chongqing Lummy Pharmaceutical is the sale of 90,000 shares on September 12, 2014, which brought Fu Rong around $3 Million.

Insider Trading History of Fu Rong

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Fu Rong Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Fu Rong Ownership Network

Ownership Network List of Fu Rong

No Data

Ownership Network Relation of Fu Rong

Insider Network Chart

Fu Rong Owned Company Details

What does Chongqing Lummy Pharmaceutical do?

Who are the key executives at Chongqing Lummy Pharmaceutical?

Fu Rong is the Executives of Chongqing Lummy Pharmaceutical. Other key executives at Chongqing Lummy Pharmaceutical include Executives lai wen , Supervisors Yuan Yuan , and Directors & executives Qiu Yu .

Chongqing Lummy Pharmaceutical (SZSE:300006) Insider Trades Summary

Over the past 18 months, Fu Rong made no insider transaction in Chongqing Lummy Pharmaceutical (SZSE:300006). Other recent insider transactions involving Chongqing Lummy Pharmaceutical (SZSE:300006) include a net purchase of 2,500 shares made by lai wen ,

In summary, during the past 3 months, insiders sold 0 shares of Chongqing Lummy Pharmaceutical (SZSE:300006) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Chongqing Lummy Pharmaceutical (SZSE:300006) were sold and 2,500 shares were bought by its insiders, resulting in a net purchase of 2,500 shares.

Chongqing Lummy Pharmaceutical (SZSE:300006)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Chongqing Lummy Pharmaceutical Insider Transactions

No Available Data

Fu Rong Mailing Address

Above is the net worth, insider trading, and ownership report for Fu Rong. Currently GuruFocus does not have mailing address information for Fu Rong.